Signatur Biosciences
Signatur Biosciences makes precision diagnostics more accessible, starting by bringing breast cancer testing within reach for women around the world.
Signatur Biosciences has raised €6.2M across 1 funding round from 3 investors, most recently a round in May 2025. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKwww.signatur.bio ↗
Total raised
€6.2M
€6,189,760
Funding rounds
1
Investors
3
distinct backers
Active since
2025-05
latest 2025-05
Funding by year
EUR raised per yearSignatur Biosciences — funding by year — interactive chart.
Data table
| Signatur Biosciences — funding by year | |
|---|---|
| 2025 | €6.2M |
Signals
High confidenceRaise-next likelihood42
base rate 30% for Other
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-05-22 | Other | €6.2M | Noshaq,strategic backers,The Discovery Lab of IBA | View deal → |